Genotyping Assay Market by Product & Services (Reagents & Kits, Instruments, Services) Technique (PCR, Sequencing, Electrophoresis), End Users (Diagnostic & Research laboratories, Pharmaceutical & Bio Technique Companies) and Region - Analysis & Forecast 2019-2030
Report ID : 7 | Published Date : Jan 2019 | Pages : 150 | Region : Global | Report Code : BT-03
Genotyping Assay Market Overview and Introduction
The global genotyping assay market was valued at over US$ 7 Bn. in 2017 and is expected to grow at a double digit CAGR during the forecasted period.The global Genotyping Assay market is segmented by product & services, technique, end user, and region.
Genotyping Assay technology is widely used in determining the sequence in DNA or genetic make-up by comparison with other sequence or reference sequence. Various methods are used to determine sequence in genotyping assay that includes PCR, DNA microarrays, RAPD among others.
The global Genotyping Assay market is driven by technological advancements in the genomics arena, increasing research expenditure in genetics, reduced price of DNA sequencing and rise in genetic diseases are some major factors driving the market.
Genotyping Assay Market by Product & Services
On the basis of product & services, the genotyping assay market is segmented into reagents & kits, instruments and genotyping assay services. Reagents & kits accounted for the largest share of the market owing to growing number of genetic research and need to develop personalized medicine as there is a rise in genetic disorders.
Genotyping Assay Market by Technique
Based on technique, the market is segmented into PCR, Sequencing, electrophoresis and other techniques. The PCR segment is estimated to account for the largest share of the global genotyping assay market. The large share of this segment can be attributed to the technological advancement in PCR instrument and rise in application of PCR technology in genetic, prenatal, and forensic testing.
Genotyping Assay Market by End Users
On the basis of end user, the genotyping assay market is segmented into diagnostic & research laboratories, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the genotyping assay market. Need for developing personalized medicine & drug and to counter the growing diseases related to genetic disorders are some of the factors driving the growth of end-user segment.
Genotyping Assay Market by Regions
The global Genotyping Assay market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of genotyping assay, followed by Europe and Asia Pacific. North America will continue to dominate the global genotyping assay market in the forecast period owing to factors such as highly developed healthcare system and presence of private and public funding. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the Genotyping Assay market in this region.
Genotyping Assay Market Prominent Players
The prominent players in the global Genotyping Assay market are Agilent Technologies, Thermo Fisher Scientific, Illumina, QIAGEN N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, PerkinElmer, and GENEWIZ, among others.